3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Lung Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non-Small Cell Lung Cancer Metastatic
1
Neoplasms
1
Melanoma
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Endometrial Neoplasms
1
Interventions
Radiosurgery
9
Temozolomide
8
Magnetic Resonance Spectroscopy
5
pembrolizumab
4
Specimen Handling
4
Nivolumab
4
Bevacizumab
4
Receptors, Interleukin-8B
3
Memantine
3
trastuzumab deruxtecan
2
abemaciclib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Radiotherapy
2
Radiation
2
Mental Status and Dementia Tests
2
Ipilimumab
2
Biopsy
2
sotorasib
1
sapanisertib
1
sacituzumab govitecan
1
ribociclib
1
pertuzumab
1
osimertinib
1
lenvatinib
1
fluciclovine F-18
1
entrectinib
1
elacestrant
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
patritumab deruxtecan
×
30 days
×
Clear all
No trials found.